Corbus Pharmaceuticals Presents 1-Year Systemic Sclerosis and 6-Month Dermatomyositis Data from Open-Label Extension of Phase 2 Lenabasum Studies at EULAR 2018

World News: . []

Norwood MA June 13 2018 GLOBE NEWSWIRE -- Corbus Pharmaceuticals Holdings Inc NASDAQ CRBP Corbus or the "Company"), a Phase 3 clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics to tre...

More news and information about Corbus Pharmaceuticals Holdings, Inc.

Published By:

Globe Newswire: 14:29 GMT Wednesday 13th June 2018

Published: .

Search for other references to "corbus" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.
Privacy Policy | Terms and Conditions | Contact Us